Rapport Therapeutics, Inc. (NASDAQ:RAPP) Cap table

Rapport Therapeutics, Inc.

Cap table

Built by 6ix from Rapport Therapeutics, Inc.’s releases · as of Nov 4, 2026

Common shares
59,279,630
Fully diluted
59,279,630

Fully diluted

LineSharesAs of
Common shares59,279,630Nov 2, 2026

Share count over time

CountShares
Nov 22, 202659,279,630
Nov 2, 202660,708,201
Nov 2, 202659,279,630